0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

life sciences

technology-artificial-insemination

The life sciences sector is facing a wide array of challenges, including the need to fund the long path of drug discovery from initial patent application through to product approval and protecting the benefits of that hard-won innovation. Our clients are at the forefront of that innovation, meeting medical need and taking life-saving or enhancing products to market worldwide.

They need a team of lawyers that understands the drug development process and the challenges innovators face. Our expert team understands the drug development process and the challenges faced, providing the right mix of skills and experience that helps them protect, develop and defend their intellectual property, collaborate with other sector players and raise the finance necessary to pursue their goals.

We work on a cross-border basis and our membership of the international network, Pangea Net, ensures we have the expertise and resources to support our clients' needs across a range of jurisdictions, including in emerging markets.

what we do...

  • Our clients – range from funders of life sciences, private equity houses, drug development companies, multinational pharmaceuticals, diagnostics companies, medical device manufacturers and research universities.

  • Our people – many of our team have completed secondments to large pharmaceutical companies and have first-hand experience of their legal issues. Many have also had an interest in this sector since the start of their career, with the majority of our lawyers graduating with chemistry degrees. 

  • Working in partnership – we work in close partnership with our clients to deliver a tailored and responsive service that exceeds expectations and, , achieving the desired results.


  • Complete solution – whether you require advice on restructuring, equity fundraising, debt finance, mergers, acquisitions, disposals, spin outs, collaborations, contracts, licensing, patents (including entitlement, validity, enforcement and freedom to operate issues), material transfer agreements, distribution agreements, clinical trial agreements, non-disclosure agreements or studentship agreements, we can provide specialist advice based on experience in this sector.

  • Risk management - we guide you on the many issues, risks and barriers in the life sciences sector, including regulatory compliance, contractual risks and managing stakeholder concerns.

focus on...

What happens within the culture of an organisation when failure is not an option?

Our discussion starts with Kweku Adoboli recounting his experiences during the 2011 UBS Swiss bank scandal, and moves to the various lessons learned and the potential solutions for minimising the risk of wrongdoing.

View

Legal updates

Government confronts unfair practices in the leasehold market

In August 2017 we published an article on the upcoming consultation proposing reforms to tackle ‘unfair practices in the leasehold market’.

View

Commercial and data protection law update - hear from Richard Nicholas

In this session Richard Nicholas takes a look at contract creation – in particular, the contract that was made in a pub in the case of Blue v Ashley.

View

Hear from Richard Nicholas for the latest developments in contract law

Richard Nicholas talks about the changes in contract law over the last six months and particularly how time plays a difference.

View

recent experience

related opinions